{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:36:08Z","timestamp":1792888568600,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015337","name":"Guangdong Medical University","doi-asserted-by":"publisher","award":["4SG24016G"],"award-info":[{"award-number":["4SG24016G"]}],"id":[{"id":"10.13039\/501100015337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515010342"],"award-info":[{"award-number":["2024A1515010342"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.118008","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:02:22Z","timestamp":1777129342000},"page":"118008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["GLUL drives metabolic reprogramming and confers docetaxel resistance in prostate cancer"],"prefix":"10.1016","volume":"250","author":[{"given":"Zihang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2026.118008_b0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2026.118008_b0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2011.08.026","article-title":"Contemporary role of androgen deprivation therapy for prostate cancer","volume":"61","author":"Pagliarulo","year":"2012","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118008_b0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1470-2045(11)70063-8","article-title":"Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial","volume":"12","author":"Denham","year":"2011","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118008_b0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1012348","article-title":"Radiotherapy and short-term androgen deprivation for localized prostate cancer","volume":"365","author":"McGowan","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118008_b0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2021.06.010","article-title":"OLIGOPELVIS GETUG P07, a multicenter phase II trial of combined high-dose salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses in prostate cancer","volume":"80","author":"Supiot","year":"2021","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118008_b0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.bcp.2026.118008_b0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.6004\/jnccn.2021.0008","article-title":"NCCN guidelines insights: prostate cancer, Version 1.2021","volume":"19","author":"Schaeffer","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"10","key":"10.1016\/j.bcp.2026.118008_b0040","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bcp.2026.118008_b0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2013.07.003","article-title":"Androgen receptors in hormone-dependent and castration-resistant prostate cancer","volume":"140","author":"Shafi","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.118008_b0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pharmthera.2018.11.004","article-title":"Altered cancer metabolism in mechanisms of immunotherapy resistance","volume":"195","author":"Ramapriyan","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2026.118008_b0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1152\/jappl.1974.36.6.693","article-title":"Intracellular free amino acid concentration in human muscle tissue","volume":"36","author":"Bergstr\u00f6m","year":"1974","journal-title":"J. Appl. Physiol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118008_b0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc.2016.114","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"7239","key":"10.1016\/j.bcp.2026.118008_b0065","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.bcp.2026.118008_b0070","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1158\/0008-5472.CAN-11-1821","article-title":"Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res."},{"issue":"6468","key":"10.1016\/j.bcp.2026.118008_b0075","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.bcp.2026.118008_b0080","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1242\/jcs.181016","article-title":"Cancer metabolism at a glance","volume":"129","author":"Vazquez","year":"2016","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.bcp.2026.118008_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.09.056","article-title":"Glutamine anabolism plays a critical role in pancreatic cancer by coupling carbon and nitrogen metabolism","volume":"29","author":"Bott","year":"2019","journal-title":"Cell Rep."},{"issue":"7721","key":"10.1016\/j.bcp.2026.118008_b0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41586-018-0466-7","article-title":"Role of glutamine synthetase in angiogenesis beyond glutamine synthesis","volume":"561","author":"Eelen","year":"2018","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bcp.2026.118008_b0095","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3390\/cancers11121945","article-title":"GLUL ablation can confer drug resistance to cancer cells via a malate-aspartate shuttle-mediated mechanism","volume":"11","author":"Muthu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118008_b0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1476-4598-13-239","article-title":"MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer","volume":"13","author":"Shajahan-Haq","year":"2014","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2026.118008_b0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/biom11040492","article-title":"Current status and future perspectives of androgen receptor inhibition therapy for prostate cancer: a comprehensive review","volume":"11","author":"Kim","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bcp.2026.118008_b0110","first-page":"35","article-title":"Glutamine synthetase regulates the immune microenvironment and cancer development through inflammatory pathways","volume":"24","author":"Wu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2026.118008_b0115","first-page":"1235","article-title":"Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)","volume":"9","author":"Hong","year":"2022","journal-title":"Genes Dis."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:34:32Z","timestamp":1792888472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226003412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"alternative-id":["S0006295226003412"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118008","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLUL drives metabolic reprogramming and confers docetaxel resistance in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118008"}}